Integrate Evidence With Clinical Expertise and Patient Preferences and Values

Topics:

Nursing is often referred to as both an art and a science. Evidence-based practitioners must combine understanding the science of health, illness, and disease with the art of adapting care to individual patients and situations, all while thinking critically to improve patient outcomes.

Two Bacteria Species Connected to Certain Colon Cancers

Topics:

Bacteroides fragilis and Escherichia coli appear to collaborate to promote hereditary and sporadic colon cancers, according to the results of studies published in Cell Host and Microbe and Science.

FDA Approves Brentuximab Vedotin for Previously Untreated Stage III, IV Classical Hodgkin Lymphoma

Topics:

On March 20, 2018, the U.S. Food and Drug Administration (FDA) approved brentuximab vedotin to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma in combination with chemotherapy.

ONS Develops Wallet Cards to Coordinate Care for Patients Receiving Immunotherapy

Topics:

How ONS Supports Oncology Nurse Navigators in Care Coordination

Topics:

When I worked in the clinical setting, like many of you, I guided patients through treatments, prepared them for managing their care at home, celebrated the completion of treatment, and grieved the deaths of many. I coordinated patients’ care.

The Case of the Pain Paradox: Follow-Up and Clinical Trial

Topics:

The January 2018 case study introduced Vince, a 55-year-old man receiving chemotherapy and radiation for recurrent bladder cancer. He suffers from chronic back pain because of spinal stenosis and has been on opioid therapy for nearly two years.

Right-to-Try Bill Fails to Pass House; Bipartisan Bill Introduced to Help Patients Navigate Cancer Care; President’s Cancer Panel Urges Action to Lower Drug Costs

Topics:

Legislation ushering experimental drugs and treatments to patients without U.S. Food and Drug Administration (FDA) approval hit a snag on March 13, 2018, after it failed to garner enough votes in the House of Representatives. The right-to-try bill, a priority for the Trump administration, didn’t accrue the two-thirds majority vote needed to pass it along to the Senate. Lawmakers opposed to the bill had lingering questions about the safety concerns connected to bypassing FDA regulations for patients searching for new treatments. Patient advocacy groups have been speaking out against tenets of the bill, expressing concern for removing the FDA from the process.

ONS Members Help Define Checkpoint Inhibitor Adverse Event Guidelines

Topics:

Because the treatment of symptoms, side effects, and adverse events associated with immunotherapies can differ greatly from the standard of care, the American Society of Clinical Oncology (ASCO) and National Comprehensive Cancer Network (NCCN)—along with experts from ONS staff and membership—collaborated to develop guidelines to inform clinicians about managing immune-related adverse events associated with checkpoint inhibitor therapy.

National Agencies Recognize Oncology Nursing’s Role in Coordinated Patient Care

Topics:

We live in the greatest age of scientific discovery and medical breakthroughs. Advances in the innovation and understanding of diseases are providing more insight into how we treat, and often cure, people with life-threatening illnesses. What was once deemed a death sentence diagnosis is now described as a chronic disorder, that can be handled with the help of the patient and a team of healthcare providers.

Oncology Nurses Can Help Patients Understand At-Home Genetic Testing

Topics:

Direct-to-consumer genetic testing (DTCGT) has entered the prime-time stage. It’s difficult to watch TV without seeing ads touting the simplicity of DTCGT and what it can tell you, and it even made Oprah’s 2017 Favorite Things List.

Subscribe to